Ole Abildgaard - 01 Aug 2023 Form 3 Insider Report for RENOVARO BIOSCIENCES INC. (RENB)

Role: 10%+ Owner
Signature: /s/ Ole Abildgaard
Issuer symbol: RENB
Transactions as of: 01 Aug 2023
Transactions value $: $0
Form type: 3
Date filed: 06 Oct 2023, 16:32
Next filing: 20 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	RENB	Common Stock						3.46M	01 Aug 2023	By Paseco ApS
holding	RENB	Common Stock						5K	01 Aug 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	RENB	Series A Convertible Preferred Stock							01 Aug 2023	Common Stock	3.44M	$0.00	By Paseco ApS	F1, F2
holding	RENB	Warrants (right to buy)							01 Aug 2023	Common Stock	125K	$1.14	By Paseco ApS	F2
holding	RENB	Warrants (right to buy)							01 Aug 2023	Common Stock	1.42M	$0.53	By Paseco ApS	F2
holding	RENB	Warrants (right to buy)							01 Aug 2023	Common Stock	1.72M	$0.65	By Paseco ApS	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Series A Convertible Preferred Stock ("Preferred Stock") is convertible into Common Stock on a one-for-ten basis and has no expiration date
F2	Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.